{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Coumarins", "Depression", "Memory", "Mice", "Nicotine"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27080866", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "15"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "04", "Day": "14"}], "ELocationID": ["10.1007/s00213-016-4279-9"], "Language": ["eng"], "Journal": {"ISSN": "1432-2072", "JournalIssue": {"Volume": "233", "Issue": "12", "PubDate": {"Year": "2016", "Month": "Jun"}}, "Title": "Psychopharmacology", "ISOAbbreviation": "Psychopharmacology (Berl)"}, "ArticleTitle": "In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone.", "Pagination": {"StartPage": "2289", "EndPage": "2300", "MedlinePgn": "2289-300"}, "Abstract": {"AbstractText": ["Nicotine, a dominant alkaloid found in tobacco, is responsible for physical dependence, as well as addiction to cigarette smoking; consequently, smoking cessation is a very difficult process. Hepatic cytochrome P-450 2A6 (CYP2A6) is involved in the 70-80\u00a0% of the initial metabolism of nicotine and its co-metabolites. As this metabolism is slowed by inhibitors of CYP2A6, this kind of enzymatic inhibition has been proposed as a novel target for smoking cessation.", "Nicotine administered alone improved memory acquisition and consolidation as well as exerted antidepressive activity in animal models. These effects persist for 24\u00a0h. However, they are completely extinguished 48\u00a0h after administration.", "To investigate if the coumarins prolong the behavioral effects of nicotine, the forced swimming test (FST)-animal models of depression, and passive avoidance (PA) test-memory and learning paradigm were used.", "This study revealed that three CYP2A6 inhibitors: two furanocoumarins, xanthotoxin (15\u00a0mg/kg) and bergapten (25\u00a0mg/kg), and the simple coumarin umbelliferone (25\u00a0mg/kg), prolonged the antidepressive and procognitive effects of nicotine.", "These natural products may offer a new approach to the treatment of nicotinism as antidepressant and memory improvement actions are one of the main factors of nicotine dependence."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Lublin, Poland. basia.budzynska@umlub.pl."}], "LastName": "Budzynska", "ForeName": "Barbara", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy with Medicinal Plants Unit, Medical University of Lublin, Lublin, Poland."}], "LastName": "Skalicka-Wozniak", "ForeName": "Krystyna", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Lublin, Poland."}], "LastName": "Kruk-Slomka", "ForeName": "Marta", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Lublin, Poland."}], "LastName": "Wydrzynska-Kuzma", "ForeName": "Malgorzata", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Lublin, Poland."}], "LastName": "Biala", "ForeName": "Grazyna", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Psychopharmacology (Berl)", "NlmUniqueID": "7608025", "ISSNLinking": "0033-3158"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Nicotinic Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Nootropic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Umbelliferones"}, {"RegistryNumber": "4FVK84C92X", "NameOfSubstance": "5-Methoxypsoralen"}, {"RegistryNumber": "60Z60NTL4G", "NameOfSubstance": "7-hydroxycoumarin"}, {"RegistryNumber": "6M3C89ZY6R", "NameOfSubstance": "Nicotine"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "Cytochrome P-450 CYP2A6"}, {"RegistryNumber": "U4VJ29L7BQ", "NameOfSubstance": "Methoxsalen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "5-Methoxypsoralen"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Avoidance Learning"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Coumarins"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Cytochrome P-450 CYP2A6"}, {"QualifierName": ["psychology"], "DescriptorName": "Depression"}, {"QualifierName": ["drug effects"], "DescriptorName": "Locomotion"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Memory"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Methoxsalen"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Nicotine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Nicotinic Agonists"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Nootropic Agents"}, {"QualifierName": ["psychology"], "DescriptorName": "Swimming"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Umbelliferones"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abed MJ, de las Heras B, Silvan AM, Pascual R, Bermejo P, Rodriquez B, Villar AM. Effects of furocoumarins from Cachrys trifida on some macrophage functions. J Pharm Pharmacol. 2001;53:163\u2013168.", "ArticleIdList": ["11518028"]}, {"Citation": "Abel T, Lattal KM. Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr Opin Neurobiol. 2001;11(2):180\u2013187. doi: 10.1016/S0959-4388(00)00194-X.", "ArticleIdList": ["10.1016/S0959-4388(00)00194-X", "11301237"]}, {"Citation": "Al Koudsi N, Hoffmann EB, Assadzadeh A, Tyndale RF. Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors. Eur J Clin Pharmacol. 2010;66(3):239\u201351. doi: 10.1007/s00228-009-0762-0.", "ArticleIdList": ["10.1007/s00228-009-0762-0", "PMC4712028", "20012030"]}, {"Citation": "Allami N, Javadi-Paydar M, Rayatnia F, Sehhat K, Rahimian R, Norouzi A, Dehpour AR. Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice. Eur J Pharmacol. 2011;650:240\u2013248. doi: 10.1016/j.ejphar.2010.10.007.", "ArticleIdList": ["10.1016/j.ejphar.2010.10.007", "20951129"]}, {"Citation": "Alsharari SD, Siu EC, Tyndale RF, Damaj MI. Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor. Nicotine Tob Res. 2014;16(1):18\u201325. doi: 10.1093/ntr/ntt105.", "ArticleIdList": ["10.1093/ntr/ntt105", "PMC3864487", "23884323"]}, {"Citation": "Bagdas D, Muldoon PP, Zhu AZ, Tyndale RF, Damaj MI. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice. Neuropharmacology. 2014;85:67\u201372. doi: 10.1016/j.neuropharm.2014.05.006.", "ArticleIdList": ["10.1016/j.neuropharm.2014.05.006", "PMC4106981", "24859605"]}, {"Citation": "Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57\u201371. doi: 10.1146/annurev.pharmtox.48.113006.094742.", "ArticleIdList": ["10.1146/annurev.pharmtox.48.113006.094742", "PMC2946180", "18834313"]}, {"Citation": "Bethus I, Tse D, Morris RG. Dopamine and memory: modulation of the persistence of memory for novel hippocampal NMDA receptor-dependent paired associates. J Neurosci. 2010;30(5):1610\u20138. doi: 10.1523/JNEUROSCI.2721-09.2010.", "ArticleIdList": ["10.1523/JNEUROSCI.2721-09.2010", "PMC6633999", "20130171"]}, {"Citation": "Biala G, Polak P, Michalak A, Kruk-Slomka M, Budzynska B. Influence of calcium channel antagonists on nonsomatic signs of nicotine and D-amphetamine withdrawal in mice. Pharmacol Rep. 2014;66(2):212\u2013222. doi: 10.1016/j.pharep.2014.02.003.", "ArticleIdList": ["10.1016/j.pharep.2014.02.003", "24911072"]}, {"Citation": "Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol. 1995;281:319\u2013326. doi: 10.1016/0014-2999(95)00266-N.", "ArticleIdList": ["10.1016/0014-2999(95)00266-N", "8521916"]}, {"Citation": "Budzynska B, Kruk-Slomka M, Skalicka-Wozniak K, Biala G, Glowniak K. The effects of imperatorin on anxiety and memory-related behavior in male Swiss mice. Exp Clin Psychopharmacol. 2012;20:325\u2013332. doi: 10.1037/a0028391.", "ArticleIdList": ["10.1037/a0028391", "22686497"]}, {"Citation": "Budzynska B, Boguszewska-Czubara A, Kruk-Slomka M, Skalicka-Wozniak K, Michalak A, Musik I, Biala G (2015) Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice. Psychopharmacology (Berl) 232(5):931\u2013942", "ArticleIdList": ["PMC4325182", "25189792"]}, {"Citation": "Budzynska B, Boguszewska-Czubara A, Kruk-Slomka M, Skalicka-Wozniak K, Michalak A, Musik I, Biala G, Glowniak K. Effects of imperatorin on nicotine-induced anxiety- and memory-related responses and oxidative stress in mice. Physiol Behav. 2013;122:46\u201355. doi: 10.1016/j.physbeh.2013.08.019.", "ArticleIdList": ["10.1016/j.physbeh.2013.08.019", "23999469"]}, {"Citation": "Budzynska B, Polak P, Biala G. Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm. Behav Brain Res. 2012;228(1):144\u2013150. doi: 10.1016/j.bbr.2011.12.003.", "ArticleIdList": ["10.1016/j.bbr.2011.12.003", "22178315"]}, {"Citation": "Chang TKH, Waxman DJ. Cytochromes. Metabolic and toxicological aspects. 1996. The CYP2A5 subfamily; pp. 430\u2013432."}, {"Citation": "Chimakurthy J, Talasila M (2010) Effects of curcumin on pentylenetetrazole-induced anxiety-like behaviors and associated changes in cognition and monoamine levels. Psychol Neurosci 3:239\u2013244"}, {"Citation": "Cuciureanu M, Vlase L, Muntean D, Varlan I, Cuciureanu R. Grapefruit juice-drug interactions: importance for pharmacotherapy. Rev Med Chir Soc Med Nat Iasi. 2010;114(3):885\u2013891.", "ArticleIdList": ["21235125"]}, {"Citation": "Damaj MI, Siu EC, Sellers EM, Tyndale RF, Martin BR. Inhibition of nicotine metabolism by methoxsalen: pharmacokinetic and pharmacological studies in mice. J Pharmacol Exp Ther. 2007;320(1):250\u2013257. doi: 10.1124/jpet.106.111237.", "ArticleIdList": ["10.1124/jpet.106.111237", "17021260"]}, {"Citation": "Dani JA, De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav. 2001;70:439\u2013446. doi: 10.1016/S0091-3057(01)00652-9.", "ArticleIdList": ["10.1016/S0091-3057(01)00652-9", "11796143"]}, {"Citation": "File SE, Cheeta S, Kenny PJ. Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur J Pharmacol. 2000;393:231\u2013236. doi: 10.1016/S0014-2999(99)00889-4.", "ArticleIdList": ["10.1016/S0014-2999(99)00889-4", "10771018"]}, {"Citation": "Garcia-Argaez AN, Ramirez Apan TO, Parra Delgado H, Velazquez G, Martinez-Vazquez M. Anti-inflammatory activity of coumarins from Decatropis bicolor on TPA ear mice model. Planta Med. 2000;66:279\u2013281. doi: 10.1055/s-2000-14894.", "ArticleIdList": ["10.1055/s-2000-14894", "10821059"]}, {"Citation": "Gil-Bea FJ, Solas M, Mateos L, Winblad B, Ram\u00edrez MJ, Cedazo-M\u00ednguez A. Cholinergic hypofunction impairs memory acquisition possibly through hippocampal arc and BDNF downregulation. Hippocampus. 2011;21(9):999\u20131009.", "ArticleIdList": ["20865740"]}, {"Citation": "Hayase T. Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors. BMC Pharmacol. 2011;11:16. doi: 10.1186/1471-2210-11-6.", "ArticleIdList": ["10.1186/1471-2210-11-6", "PMC3155896", "21767384"]}, {"Citation": "Herman AI, Sofuoglu M. Comparison of available treatments for tobacco addiction. Curr Psychiatry Rep. 2010;12:433\u2013440. doi: 10.1007/s11920-010-0134-6.", "ArticleIdList": ["10.1007/s11920-010-0134-6", "PMC2935501", "20623259"]}, {"Citation": "Hiramatsu M, Murasawa H, Nabeshima T, Kameyama T. Effects of U-50,488H on scopolamine, mecamylamine and dizocilpine-induced learning and memory impairment in rats. J Pharmacol Exp Ther. 1998;284:858\u2013867.", "ArticleIdList": ["9495843"]}, {"Citation": "Ho PC, Saville DJ, Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci. 2001;4(3):217\u201327.", "ArticleIdList": ["11737987"]}, {"Citation": "Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9:315\u2013327. doi: 10.1080/14622200701188919.", "ArticleIdList": ["10.1080/14622200701188919", "17365764"]}, {"Citation": "Hukkanen J, Jacob P, III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharm Rev. 2005;57:79\u2013115. doi: 10.1124/pr.57.1.3.", "ArticleIdList": ["10.1124/pr.57.1.3", "15734728"]}, {"Citation": "Huong DTL, Choi HC, Rho TC, Lee HS, Lee MK, Kim YH. Inhibitory activity of monoamine oxidase by coumarins from Peucedanum japonicum. Arch Pharm Res. 1999;22(3):324\u2013326. doi: 10.1007/BF02976373.", "ArticleIdList": ["10.1007/BF02976373", "10403141"]}, {"Citation": "Javadi-Paydar M, Zakeri M, Norouzi A, Rastegar H, Mirazi N, Dehpour A. Involvement of nitric oxide in granisetron improving effects on scopolamine-induced memory impairment in mice. Brain Res Rev. 2012;1429:61\u201371. doi: 10.1016/j.brainres.2011.08.006.", "ArticleIdList": ["10.1016/j.brainres.2011.08.006", "21875703"]}, {"Citation": "Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y, Ito C, Furukawa H. Antiproliferative effects of isopentenylated coumarins on several cancer cell lines. Anticancer Res. 2001;21:1905\u20131911.", "ArticleIdList": ["11497276"]}, {"Citation": "Kielbus M, Skalicka-Wozniak K, Grabarska A, Jeleniewicz W, Dmoszynska-Graniczka M, Marston A, Polberg K, Gawda P, Klatka J, Stepulak A. 7-substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro. Anticancer Res. 2013;33:4347\u20134356.", "ArticleIdList": ["24123002"]}, {"Citation": "Kruk-Slomka M, Budzynska B, Biala G. Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice. Pharmacol Rep. 2012;64(5):1066\u20131080. doi: 10.1016/S1734-1140(12)70904-0.", "ArticleIdList": ["10.1016/S1734-1140(12)70904-0", "23238464"]}, {"Citation": "Levin ED. Nicotinic receptor subtypes and cognitive function. J Neurobiol. 2002;53:633\u2013640. doi: 10.1002/neu.10151.", "ArticleIdList": ["10.1002/neu.10151", "12436426"]}, {"Citation": "Levin ED, Petro A, Rezvani AH, Pollard N, Christopher NC, Strauss M, Avery J, Nicholson J, Rose JE. Nicotinic \u03b17- or \u03b22-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behav Brain Res. 2009;196:207\u2013213. doi: 10.1016/j.bbr.2008.08.048.", "ArticleIdList": ["10.1016/j.bbr.2008.08.048", "PMC2638590", "18831991"]}, {"Citation": "Levin ED, Rezvani A. Nicotinic interactions with antipsychotic drug models of schizophrenia and impacts on cognitive function. Biochem Pharmacol. 2007;74:1182\u20131191. doi: 10.1016/j.bcp.2007.07.019.", "ArticleIdList": ["10.1016/j.bcp.2007.07.019", "PMC2702723", "17714691"]}, {"Citation": "Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol. 1997;8:523\u2013532. doi: 10.1097/00008877-199711000-00010.", "ArticleIdList": ["10.1097/00008877-199711000-00010", "9832966"]}, {"Citation": "Luszczki JJ, Anders-Mach M, Glensk M, Skalicka-Wozniak K. Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: a comparative study. Pharmacol Rep. 2010;62:1231\u20131236. doi: 10.1016/S1734-1140(10)70387-X.", "ArticleIdList": ["10.1016/S1734-1140(10)70387-X", "21273683"]}, {"Citation": "Luszczki JJ, Glowniak K, Czuczwar SJ. Time-course and dose-response relationships of imperatorin in the mouse maximal electroshock seizure threshold model. Neurosci Res. 2007;59:18\u201322. doi: 10.1016/j.neures.2007.05.004.", "ArticleIdList": ["10.1016/j.neures.2007.05.004", "17602770"]}, {"Citation": "Malin DH. Nicotine dependence studies with a laboratory model. Pharmacol Biochem Behav. 2001;70:551\u2013559. doi: 10.1016/S0091-3057(01)00699-2.", "ArticleIdList": ["10.1016/S0091-3057(01)00699-2", "11796153"]}, {"Citation": "Marubio LM, Arroyo-Jimenez MDM, Cordero-Erausquin M, L\u00e9na C, Le Nov\u00e8re N, de Kerchove d\u2019Exaerde A, Huchet M, Damaj MI, Changeux JP. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999;398:805\u2013810. doi: 10.1038/19756.", "ArticleIdList": ["10.1038/19756", "10235262"]}, {"Citation": "Murphy SE, Raulinaitis V, Brown KM. Nicotine 5\u2032-oxidation and methyl oxidation by P450 2A enzymes. Drug Metab Dispos. 2005;33:1166\u20131173. doi: 10.1124/dmd.105.004549.", "ArticleIdList": ["10.1124/dmd.105.004549", "15860657"]}, {"Citation": "O\u2019Kennedy R, Thornes D. Coumarins: biology, applications and mode of action. Chichester: Wiley & Sons; 1997."}, {"Citation": "Raunio H, Pokela N, Puhakainen K, Rahnasto M, Mauriala T, Auriola S, Juvonen RO. Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo. Xenobiotica. 2008;38(1):34\u201347. doi: 10.1080/00498250701708539.", "ArticleIdList": ["10.1080/00498250701708539", "18098062"]}, {"Citation": "Raunio H, Rahnasto-Rilla M. CYP2A6: genetics, structure, regulation, and function. Drug Metabol Drug Interact. 2012;27(2):73\u201388. doi: 10.1515/dmdi-2012-0001.", "ArticleIdList": ["10.1515/dmdi-2012-0001", "22706231"]}, {"Citation": "Raunio H, Rautio A, Gullst\u00e9n H, Pelkonen O. Polymorphisms of CYP2A6 and its practical consequences. Br J Clin Pharmacol. 2001;52(4):357\u2013363. doi: 10.1046/j.0306-5251.2001.01500.x.", "ArticleIdList": ["10.1046/j.0306-5251.2001.01500.x", "PMC2014580", "11678779"]}, {"Citation": "Robinson L, Platt B, Riedel G. Involvement of the cholinergic system in conditioning and perceptual memory. Behav Brain Res. 2011;221(2):443\u201365. doi: 10.1016/j.bbr.2011.01.055.", "ArticleIdList": ["10.1016/j.bbr.2011.01.055", "21315109"]}, {"Citation": "Sellers EM, Ramamoorthy Y, Zeman MV, Djordjevic MV, Tyndale RF. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo. Nicot Tob Res. 2003;5(6):891\u20139. doi: 10.1080/14622200310001615231.", "ArticleIdList": ["10.1080/14622200310001615231", "14668073"]}, {"Citation": "Senol FS, Skalicka-Wozniak K, Hassan Khan MT, Orhan IE, Sener B, Glowniak K. An in vitro and in silico approach to cholinesterase inhibitory and antioxidant effects of the methanol extract, furanocoumarin fraction, and major coumarins of Angelica officinalis L. fruits. Phytochem Lett. 2011;4:462\u2013467. doi: 10.1016/j.phytol.2011.08.016.", "ArticleIdList": ["10.1016/j.phytol.2011.08.016"]}, {"Citation": "Seon HJ, Xiang HH, Seong SH, Ji SH, Ji HH, Lee D, Myung KL, Jai SR, Bang YH. Monoamine oxidase inhibitory coumarins from the aerial parts of Dictamnus albus. Arch Pharm Res. 2006;29:1119\u20131124. doi: 10.1007/BF02969302.", "ArticleIdList": ["10.1007/BF02969302", "17225461"]}, {"Citation": "Singhuber J, Baburin I, Ecker GF, Kopp B, Hering S. Insights into structure\u2013activity relationship of GABAA receptor modulating coumarins and furanocoumarins. Eur J Pharmacol. 2011;668:57\u201364. doi: 10.1016/j.ejphar.2011.06.034.", "ArticleIdList": ["10.1016/j.ejphar.2011.06.034", "PMC3196836", "21749864"]}, {"Citation": "Skalicka-Wozniak K, Mendel M, Chlopecka M, Dziekan N. Isolation and evaluation of the myorelaxant effect of bergapten on isolated rat jejunum. Pharm Biol. 2015;17:1\u20137.", "ArticleIdList": ["25885935"]}, {"Citation": "Skalicka-Wozniak K, Zagaja M, Glowniak K, Luszczki JJ. Purification and anticonvulsant activity of xanthotoxin (8-methoxypsoralen) Centr Eur J Biol. 2014;9:431\u2013436."}, {"Citation": "Stolerman IP, Shoaib M. The neurobiology of tobacco addiction. Trends Pharmacol Sci. 1991;12:467\u2013473. doi: 10.1016/0165-6147(91)90638-9.", "ArticleIdList": ["10.1016/0165-6147(91)90638-9", "1792691"]}, {"Citation": "Su T, Ding X. Regulation of the cytochrome P450 2A genes. Toxicol Appl Pharmacol. 2004;199:285\u2013294. doi: 10.1016/j.taap.2003.11.029.", "ArticleIdList": ["10.1016/j.taap.2003.11.029", "15364544"]}, {"Citation": "Venault P, Chapouthier G, de Carvalho LP, Simiand J, Moore M, Dodd RH, Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature. 1986;321:864\u2013866. doi: 10.1038/321864a0.", "ArticleIdList": ["10.1038/321864a0", "3724846"]}, {"Citation": "Visoni S, Meireles N, Monteiro L, Rossini A, Pinto LFR. Different modes of inhibition of mouse Cyp2a5 and rat CYP2A3 by the food-derived 8-methoxypsoralen. Food Chem Toxicol. 2008;46:1190\u20131195. doi: 10.1016/j.fct.2007.12.001.", "ArticleIdList": ["10.1016/j.fct.2007.12.001", "18215451"]}, {"Citation": "Yamanaka H, Nakajima M, Nishimura K, Yoshida R, Fukami T, Katoh M. Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted. European J Pharm Sci. 2004;22:419\u2013425. doi: 10.1016/j.ejps.2004.04.012.", "ArticleIdList": ["10.1016/j.ejps.2004.04.012", "15265511"]}, {"Citation": "Zaniewska M, Przegalinski E, Filip M. Nicotine dependence\u2014human and animal studies, current pharmacotherapies and future perspectives. Pharmacol Rep. 2009;61:957\u2013965. doi: 10.1016/S1734-1140(09)70157-4.", "ArticleIdList": ["10.1016/S1734-1140(09)70157-4", "20081230"]}, {"Citation": "Zhang W, Kilicarslan T, Tyndale RF, Sellers EM. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos. 2001;29:897\u2013902.", "ArticleIdList": ["11353760"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "11", "Day": "30"}, {"Year": "2016", "Month": "3", "Day": "14"}, {"Year": "2016", "Month": "4", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27080866", "PMC4873531", "10.1007/s00213-016-4279-9", "10.1007/s00213-016-4279-9"]}}], "PubmedBookArticle": []}